Aker BioMarine reported a net profit of USD 207.5 million in Q3 2024, driven by the sale of its Feed Ingredients segment, while continuing operations saw revenue decline 7% year-over-year but improved Adjusted EBITDA. Human Health Ingredients grew 8% and Consumer Health Products fell 5%.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.